A. Chutaputti

发表

What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?

T. Saibara, S. Chitturi, Jian-Gao Fan, 2007, Journal of gastroenterology and hepatology.

APASL consensus statements and management algorithms for hepatitis C virus infection

J. Kao, S. Sarin, S. Hamid, 2012, Hepatology International.

Resource Utilization and Direct Medical Costs of Chronic Hepatitis C in Thailand: A Heavy but Manageable Economic Burden.

T. Tanwandee, T. Piratvisuth, A. Chutaputti, 2014, Value in health regional issues.

Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

Y. Chao, T. Tanwandee, W. Chang, 2003, Journal of viral hepatitis.

Efficacy of Serum Hyaluronic Acid Level for Predicting Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

P. Kongtawelert, A. Chutaputti, C. Pawitpok, 2006 .

Natural history, outcome, and sustainability of treatment response in chronic viral hepatitis B: Thai multicenter study

T. Piratvisuth, S. Treeprasertsuk, V. Mahachai, 2013 .

Prevention of hepatocellular carcinoma in the Asia–Pacific region: Consensus statements

J. Kao, D. Amarapurkar, R. Mohamed, 2010, Journal of gastroenterology and hepatology.

Adverse effects and other safety aspects of the hepatitis C antivirals

A. Chutaputti, 2000, Journal of gastroenterology and hepatology.

Litchi-Derived Polyphenol Alleviates Liver Steatosis and Gut Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blinded, Placebo-Controlled Study

N. Chuaypen, P. Tangkijvanich, M. Chayanupatkul, 2022, Nutrients.

The Efficacy of Oligonol in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blinded Placebo-Controlled Trial.

P. Tangkijvanich, M. Chayanupatkul, A. Chutaputti, 2022, Journal of integrative and complementary medicine.

Management of refractory ascites and hepatorenal syndrome

A. Chutaputti, 2002, Journal of Gastroenterology and Hepatology.

Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B

M. Yuen, D. J. Kim, S. Paik, 2012, Hepatology International.

Interspousal transmission of hepatitis C in Thailand

A. Theamboonlers, Y. Poovorawan, A. Chutaputti, 2003, Journal of Gastroenterology.

Acute hepatitis associated with Barakol.

A. Chutaputti, Mongkon Hongsirinirachorn, Sombat Threeprasertsuk, 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[58] SUSTAINED OFF-TREATMENT HBeAg RESPONSE IN TELBIVUDINE AND LAMIVUDINE TREATED HBeAg-POSITIVE PATIENTS FROM THE GLOBE STUDY

S. Zeuzem, S. Lim, Samuel S. Lee, 2007 .

Chronic hepatitis B virus infection in Asian countries

N. Leung, J. Sollano, P. Phiet, 2000, Journal of gastroenterology and hepatology.

Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment‐naïve patients with HBV‐related decompensated cirrhosis

C. Yurdaydın, S. Sarin, G. Choudhuri, 2012, Journal of viral hepatitis.

Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B

G. Lau, Y. Chao, T. Tanwandee, 2008, Hepatology international.

Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C.

F. Sugauchi, R. Ueda, R. Gish, 2003, Gastroenterology.

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

Stefan Zeuzem, M. Buti, Y. Liaw, 2009, Journal of hepatology.

Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors

Yuan‐Jen Wang, Y. Chao, T. Tanwandee, 2002 .

Treatment with peginterferon alfa-2a (40KD) (PEGASYS®) results in improved rates of response compared to conventional interferon in patients with HBEAG positive chronic hepatitis B harboring HBV genotypes B or ‘difficult-to-treat’ genotype C

M. Lai, Y. Chao, T. Tanwandee, 2003 .

Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand

F. Sugauchi, R. Ueda, M. Mizokami, 2002, Journal of gastroenterology and hepatology.

Hepatocellular carcinoma in the Asia pacific region

Jin-Lin Hou, Man-Fung Yuen, M. Yuen, 2009, Journal of gastroenterology and hepatology.

Hepatitis B Virus of Genotype B with or without Recombination with Genotype C over the Precore Region plus the Core Gene

F. Sugauchi, R. Ueda, T. Ishida, 2002, Journal of Virology.

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

S. Sarin, D. Amarapurkar, S. Hamid, 2007, Journal of gastroenterology and hepatology.

Pseudotumor of the pancreas associated with retroperitoneal fibrosis: a dramatic response to corticosteroid therapy.

J. Boyer, M. Burrell, A. Chutaputti, 1995, The American journal of gastroenterology.

Spontaneous bacterial peritonitis [SBP].

A. Chutaputti, 2005, The Medical journal of Malaysia.

Prompt Diagnosis of Spontaneous Bacterial Peritonitis and Analysis of Ascites Protein Content by Reagent Strip

A. Chutaputti, Jindarat Jearjesdakul, 2005 .

Asian Pacific Association for Study of the Liver (APASL)

M. Alter, M. Hashizume, M. Manns, 2003 .

Clinical features, etiology, and survival of hepatocellular carcinoma among different countries

Ding‐Shinn Chen, B. Daniele, K. Rudolph, 2002, Journal of gastroenterology and hepatology.

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party

W. Jafri, J. Sollano, A. Chutaputti, 2007 .

7 TREATMENT OF DECOMPENSATED HBV-CIRRHOSIS: RESULTS FROM 2-YEARS RANDOMIZED TRIAL WITH TELBIVUDINE OR LAMIVUDINE

S. Sarin, N. Assy, G. Choudhuri, 2010 .